Showing results (231-240 of 366) with videos related to
Sort By:
Pageof 37
British Journal of Haematology|April 16, 2003
Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccinationMaria R Motta, Samantha Castellani, Simonetta Rizzi, et al.Anti-Cancer Agents in Medicinal Chemistry|August 5, 2021
Pharmacological Basis of Breast Cancer Resistance to Therapies - An OverviewStefania Crucitta, Federico Cucchiara, Francesca Sciandra, et al.Experimental Hematology|September 16, 2000
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patientsM Ratta, A Curti, M Fogli, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infectionRoberto Biassoni, Manuela Fogli, Claudia Cantoni, et al.Critical Reviews in Oncology/Hematology|January 22, 2022
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differencesStefano Fogli, Fabrizio Tabbò, Annalisa Capuano, et al.Blood|April 21, 2001
Interleukin-11 induces Th2 polarization of human CD4(+) T cellsA Curti, M Ratta, S Corinti, et al.Case Reports in Neurological Medicine|August 22, 2014
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous DeletionLucio Tremolizzo, Gessica Sala, Elisa Conti, et al.Biochemical Pharmacology|January 26, 2010
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptorsStefania Gessi, Valeria Sacchetto, Eleonora Fogli, et al.British Journal of Clinical Pharmacology|May 8, 2002
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patientsRomano Danesi, Federico Innocenti, Stefano Fogli, et al.Breast Cancer Research and Treatment|November 2, 2001
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II studyP F Conte, A Gennari, S Donati, et al.Pageof 37